Neuropsychiatric systemic lupus erythematosus - current and novel treatments.

Curr Opin Rheumatol · 2026 · PMC12863625 · PMID 41251208

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

The Phase 1b/2a study demonstrated a positive trend in efficacy, with a dose-dependent increase in the SLE Responder Index (SRI-4) response rate and a decrease in circulating antidsDNA antibodies compared to placebo.

also in 7,469 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.